Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jiang, Jie
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer	Recruiting	2	88	RoW	RC88, RC88 for Injection	RemeGen Co., Ltd.	Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer	06/26	12/26
NCT06251947: Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen	Recruiting	2	83	RoW	Efbemalenograstim Alfa	Shandong University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Ovarian Cancer, Cervical Cancer	06/26	12/26